Selected research
Industry Research
Neglected Tropical Diseases Drugs and Vaccine Industry Research Report 2026
Market perspective
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Neglected Tropical Diseases Drugs and Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Neglected Tropical Diseases Drugs and Vaccine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Neglected Tropical Diseases Drugs and Vaccine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Neglected Tropical Diseases Drugs and Vaccine include Artecef BV, Cipla, Lupin, Macleods Pharmaceuticals, Ranbaxy Labs, Romark Laboratories, Sanofi-Aventis, Toyama Chemica and AstraZeneca, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Neglected Tropical Diseases Drugs and Vaccine market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neglected Tropical Diseases Drugs and Vaccine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neglected Tropical Diseases Drugs and Vaccine Market by Company
Artecef BV
Cipla
Lupin
Macleods Pharmaceuticals
Ranbaxy Labs
Romark Laboratories
Sanofi-Aventis
Toyama Chemica
AstraZeneca
GlaxoSmithKline
Novartis
Neglected Tropical Diseases Drugs and Vaccine Segment by Type
Ebola
Dengue
Leishmaniasis
Chagas
Malaria
Other
Neglected Tropical Diseases Drugs and Vaccine Segment by Application
Drugs
Vaccines
Neglected Tropical Diseases Drugs and Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neglected Tropical Diseases Drugs and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neglected Tropical Diseases Drugs and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neglected Tropical Diseases Drugs and Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ebola
- Dengue
- Leishmaniasis
- Chagas
- Malaria
- Other
Applications
- Drugs
- Vaccines
Companies covered
- Artecef BV
- Cipla
- Lupin
- Macleods Pharmaceuticals
- Ranbaxy Labs
- Romark Laboratories
- Sanofi-Aventis
- Toyama Chemica
- AstraZeneca
- GlaxoSmithKline
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neglected Tropical Diseases Drugs and Vaccine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ebola
- 2.2.3 Dengue
- 2.2.4 Leishmaniasis
- 2.2.5 Chagas
- 2.2.6 Malaria
- 2.2.7 Other
- 2.3 Neglected Tropical Diseases Drugs and Vaccine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drugs
- 2.3.3 Vaccines
- 2.4 Assumptions and Limitations
3 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
- 3.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2021-2026)
- 3.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2027-2032)
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
- 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2021-2026)
- 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2021-2032)
- 5.2 Global Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
- 5.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2021-2026)
- 5.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2027-2032)
- 5.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
- 5.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
- 5.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
- 5.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
- 5.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
- 6.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2021-2026)
- 6.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2021-2026)
- 6.2 Global Neglected Tropical Diseases Drugs and Vaccine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Neglected Tropical Diseases Drugs and Vaccine Head Office and Area Served
- 6.4 Global Neglected Tropical Diseases Drugs and Vaccine Players, Product Type & Application
- 6.5 Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Established Date
- 6.6 Global Neglected Tropical Diseases Drugs and Vaccine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 7.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 7.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 8.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 8.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 9.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 10.2 South America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 10.4 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 11.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Artecef BV
- 12.1.1 Artecef BV Company Information
- 12.1.2 Artecef BV Business Overview
- 12.1.3 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.1.5 Artecef BV Recent Developments
- 12.2 Cipla
- 12.2.1 Cipla Company Information
- 12.2.2 Cipla Business Overview
- 12.2.3 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.2.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.2.5 Cipla Recent Developments
- 12.3 Lupin
- 12.3.1 Lupin Company Information
- 12.3.2 Lupin Business Overview
- 12.3.3 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.3.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.3.5 Lupin Recent Developments
- 12.4 Macleods Pharmaceuticals
- 12.4.1 Macleods Pharmaceuticals Company Information
- 12.4.2 Macleods Pharmaceuticals Business Overview
- 12.4.3 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.4.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.4.5 Macleods Pharmaceuticals Recent Developments
- 12.5 Ranbaxy Labs
- 12.5.1 Ranbaxy Labs Company Information
- 12.5.2 Ranbaxy Labs Business Overview
- 12.5.3 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.5.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.5.5 Ranbaxy Labs Recent Developments
- 12.6 Romark Laboratories
- 12.6.1 Romark Laboratories Company Information
- 12.6.2 Romark Laboratories Business Overview
- 12.6.3 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.6.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.6.5 Romark Laboratories Recent Developments
- 12.7 Sanofi-Aventis
- 12.7.1 Sanofi-Aventis Company Information
- 12.7.2 Sanofi-Aventis Business Overview
- 12.7.3 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.7.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.7.5 Sanofi-Aventis Recent Developments
- 12.8 Toyama Chemica
- 12.8.1 Toyama Chemica Company Information
- 12.8.2 Toyama Chemica Business Overview
- 12.8.3 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.8.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.8.5 Toyama Chemica Recent Developments
- 12.9 AstraZeneca
- 12.9.1 AstraZeneca Company Information
- 12.9.2 AstraZeneca Business Overview
- 12.9.3 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.9.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.9.5 AstraZeneca Recent Developments
- 12.10 GlaxoSmithKline
- 12.10.1 GlaxoSmithKline Company Information
- 12.10.2 GlaxoSmithKline Business Overview
- 12.10.3 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.10.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.10.5 GlaxoSmithKline Recent Developments
- 12.11 Novartis
- 12.11.1 Novartis Company Information
- 12.11.2 Novartis Business Overview
- 12.11.3 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2021-2026)
- 12.11.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 12.11.5 Novartis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst